Compare Howmet Aerospace Inc (HWM) vs Pfizer Inc (PFE) Price & Performance

Howmet Aerospace (HWM) trades at $225.50, up 1.26% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows bearish technical signals but maintains robust fundamentals with 20.52% net income margin and 34.89% ROE. Recent news highlights defense aerospace demand driving revenue growth, while institutional interest remains strong with Nykredit's $44.69 million investment in Q2 2026.

Outlook remains positive with 84% analyst buy ratings and $328.10 consensus price target suggesting 45% upside. Key risks include supply chain pressures and competitive threats from SpaceX's in-house initiatives. Earnings growth and defense contracts position HWM for sustained performance despite near-term technical weakness.

Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.

The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.